As the global demand for rapid and accurate diagnostic tools continues to rise, the COVID-19 (SARS-CoV-2) Antigen Rapid Test Kit has emerged as a critical solution for detecting the novel coronavirus. Developed by Gaobeidian PRISES Biotechnology Co., Ltd, this test kit combines advanced immunochromatographic technology with user-friendly design to deliver reliable results in just 10 minutes. This article provides an in-depth analysis of its features, technical specifications, applications, and the company's commitment to innovation.

Understanding the Technology: Immunochromatography with Colloidal Gold

The COVID-19 (SARS-CoV-2) Antigen Rapid Test Kit utilizes NIST-validated immunochromatography technology, a method widely recognized for its efficiency in rapid diagnostic testing. The test strip consists of two key components: a conjugate pad containing mouse anti-novel coronavirus nucleoprotein monoclonal antibodies conjugated with colloidal gold, and a nitrocellulose membrane strip with a test line (T line) and a control line (C line). The T line is pre-coated with antibodies for detecting the nucleoprotein of SARS-CoV-2, while the C line ensures the test's validity.

Key Features and Advantages

One of the standout features of this test kit is its ease of use. Unlike traditional diagnostic methods that require specialized equipment, the COVID-19 (SARS-CoV-2) Antigen Rapid Test Kit is designed for intuitive operation. Users can perform the test with minimal training, making it ideal for point-of-care settings. The results are available within 10 minutes, significantly reducing the time required for diagnosis compared to PCR tests, which often take hours or days.

The test's accuracy is another critical advantage. With a clinical sensitivity of 96.33% and a clinical specificity of 99.569%, the kit has been validated through PCR and clinical diagnosis, ensuring reliable outcomes. Additionally, its versatility allows it to work with various specimen types, including nasal swabs, oropharyngeal swabs, and nasopharyngeal swabs, making it adaptable to different clinical scenarios.

Technical Specifications

Components and Packaging

The COVID-19 (SARS-CoV-2) Antigen Rapid Test Kit comes in individually sealed foil pouches, ensuring sterility and convenience. Each kit includes one test device, a desiccant, and a set of components such as sample tubes, nasopharyngeal swabs, and quick reference instructions. The packaging is designed to accommodate up to 20 tests per carton, with customization options available to meet specific customer requirements.

Storage and Stability

To maintain the integrity of the test kit, it should be stored at temperatures between 2°C and 30°C in a dry place, away from direct sunlight. Freezing is strictly prohibited, as it may compromise the test's performance. The shelf life of the product is 24 months from the date of manufacturing. Once the aluminum foil bag is opened, the test card should be used within one hour to ensure optimal results.

Applications and Use Cases

The COVID-19 (SARS-CoV-2) Antigen Rapid Test Kit is suitable for a wide range of applications, including but not limited to:

• Point-of-care testing in clinics, pharmacies, and community health centers.
• Screening programs for asymptomatic individuals in high-risk environments such as schools, workplaces, and public transportation.
• Emergency response scenarios where rapid diagnosis is critical for containment efforts.
• Home use under the guidance of healthcare professionals, enabling individuals to monitor their health status conveniently.

Its ability to deliver quick results makes it an invaluable tool for healthcare providers and public health officials in managing the spread of SARS-CoV-2.

About Gaobeidian PRISES Biotechnology Co., Ltd

Founded with a mission to advance diagnostic solutions, Gaobeidian PRISES Biotechnology Co., Ltd has established itself as a leader in the development of rapid diagnostic kits. The company's commitment to innovation is reflected in its state-of-the-art research and development facilities, which adhere to stringent quality control standards. By leveraging cutting-edge technology and a deep understanding of clinical needs, PRISES Biotechnology continues to contribute to the global fight against infectious diseases.

Conclusion

The COVID-19 (SARS-CoV-2) Antigen Rapid Test Kit represents a significant advancement in diagnostic technology, offering a balance of speed, accuracy, and usability. As the world continues to navigate the challenges posed by the pandemic, such innovations play a vital role in safeguarding public health. For more information, visit the official website of Gaobeidian PRISES Biotechnology Co., Ltd.

References

National Institute of Standards and Technology (NIST) (2025). "Standards for Diagnostic Devices." Retrieved from https://www.nist.gov.